Screening and medication key to better outcomes
Cleveland Clinic’s Endocrinology & Metabolism Institute is working to offer novel opportunities and therapies for diabetes and kidney disease
Two major trials promise key progress against the last unaddressed major risk factor
Genetic variants may help identify which patients could benefit which patients from more aggressive glycemia treatment
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The inaugural presentation from EMI Live illustrates how research can guide treatment, but moving from bench to bedside isn’t always the easiest.
Medications for patients with diabetes and cardiovascular disease
Predictive tool should help in treatment decisions
Findings are from a large cohort study in patients with type 2 diabetes and obesity
Exploring the potential clinical outcomes of two treatment approaches
Weight fluctuations after year one less important than percentage of weight loss in year one, study suggests